BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9189837)

  • 1. Hypokalaemia in pregnant women treated with the beta 2-mimetic drug fenoterol--a concentration and time dependent effect.
    Hildebrandt R; Weitzel HK; Gundert-Remy U
    J Perinat Med; 1997; 25(2):173-9. PubMed ID: 9189837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-effect relationship of the positive chronotropic and hypokalaemic effects of fenoterol in healthy women of childbearing age.
    Bouillon T; Meineke I; Port R; Hildebrandt R; Günther K; Gundert-Remy U
    Eur J Clin Pharmacol; 1996; 51(2):153-60. PubMed ID: 8911881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
    Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
    Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
    Deenstra M; Haalboom JR; Struyvenberg A
    Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoterol-induced hepatitis in a pregnant woman: a case report.
    Fontaine P; Géhénot M; Goffin P; Horsmans Y
    Am J Obstet Gynecol; 1996 May; 174(5):1647-8. PubMed ID: 9065147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenoterol increases erythropoietin concentrations during tocolysis.
    Gleiter CH; Schreeb KH; Goldbach S; Herzog S; Cunze T; Kuhn W
    Br J Clin Pharmacol; 1998 Feb; 45(2):157-9. PubMed ID: 9491829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypokalaemia induced by inhalation of fenoterol.
    Haalboom JR; Deenstra M; Struyvenberg A
    Lancet; 1985 May; 1(8438):1125-7. PubMed ID: 2860336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic studies on fenoterol in maternal and cord blood.
    von Mandach U; Huch A; Huch R
    Am J Perinatol; 1989 Apr; 6(2):209-13. PubMed ID: 2712918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nitroglycerin patch for tocolysis--a prospective randomized comparison with fenoterol by infusion].
    Schleussner E; Richter S; Gross W; Kähler C; Möller A; Möller U; Seewald HJ
    Z Geburtshilfe Neonatol; 2001; 205(5):189-94. PubMed ID: 11727665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a need to treat hypokalaemia associated with intravenous salbutamol infusion?
    Chua S; Razvi K; Wong MT; Tay R; Arulkumaran S
    J Obstet Gynaecol Res; 1997 Aug; 23(4):381-7. PubMed ID: 9311181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [-Glucose, insulin and C-peptide kinetics during tocolysis with oral fenoterol-].
    Günter HH; Nitschmann A; Balks HJ; Wedeking-Schöhl H; Niesert S
    Gynakol Geburtshilfliche Rundsch; 1995; 35(4):215-20. PubMed ID: 8646005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe pulmonary edema associated with tocolytic therapy. Case report with hemodynamic study.
    Leduc D; Naeije R; Leeman M; Homans C; Kahn RJ
    Intensive Care Med; 1996 Nov; 22(11):1280-1. PubMed ID: 9120134
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
    Scheinin M; Koulu M; Laurikainen E; Allonen H
    Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of maternal side effects of various forms of intravenous therapy with fenoterol in premature labor].
    Herzog S; Cunze T; Osmers R; Kuhn W
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():73-9. PubMed ID: 8672931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoterol inhalation: its associated risks and potential benefits when reducing serum potassium levels.
    de los Santos CA; Traesel MA; Marini L
    Clin Nephrol; 1998 Jun; 49(6):390. PubMed ID: 9696438
    [No Abstract]   [Full Text] [Related]  

  • 17. [Right ventricular hypertrophic cardiomyopathy in the fetus --may it be caused by chronic oral tocolysis with fenoterol?].
    Hamela-Olkowska A; Szymkiewicz-Dangel J; Własienko P; Majewska U; Bokiniec R
    Ginekol Pol; 2012 Feb; 83(2):145-8. PubMed ID: 22568362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T/QRS ratio values in pregnancies complicated by threatened preterm labour treated with intravenous infusions of fenoterol.
    Fuchs T; Pomorski M; Grobelak K; Zimmer M
    J Perinat Med; 2015 Jul; 43(4):467-72. PubMed ID: 25153544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.